These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 579351)

  • 1. Thyroid autoimmune disease in a large Newfoundland family: the influence of HLA.
    Farid NR; Barnard JM; Marshall WH; Woolfrey I; O'Driscoll RF
    J Clin Endocrinol Metab; 1977 Dec; 45(6):1165-72. PubMed ID: 579351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA/Bf haplotypes in a Newfoundland family.
    Larsen B; Pepper B; Barnard JM; Farid NR
    Tissue Antigens; 1978 Jul; 12(1):39-43. PubMed ID: 581240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of HLA with autoimmune thyroid disease in Newfoundland. The influence of HLA homozygosity in Graves' disease.
    Farid NR; Barnard JM; Marshall WH
    Tissue Antigens; 1976 Sep; 8(3):181-9. PubMed ID: 989647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of human leukocyte D locus related antigens in Graves' disease.
    Farid NR; Sampson L; Noel EP; Barnard JM; Mandeville R; Larsen B; Marshall WH; Carter ND
    J Clin Invest; 1979 Jan; 63(1):108-13. PubMed ID: 105012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA haplotypes in familial Graves' disease.
    Farid NR; Moens H; Larsen B; Payne R; Saltman K; Fifield F; Ingram DW
    Tissue Antigens; 1980 May; 15(5):492-500. PubMed ID: 6893771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenetics of Hashimoto's and Graves' diseases.
    Tamai H; Uno H; Hirota Y; Matsubayashi S; Kuma K; Matsumoto H; Kumagai LF; Sasazuki T; Nagataki S
    J Clin Endocrinol Metab; 1985 Jan; 60(1):62-6. PubMed ID: 3838076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of a type A retroviral particle and class II human leukocyte antigen susceptibility genes in the pathogenesis of Graves' disease.
    Jaspan JB; Sullivan K; Garry RF; Lopez M; Wolfe M; Clejan S; Yan C; Tenenbaum S; Sander DM; Ahmed B; Bryer-Ash M
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2271-9. PubMed ID: 8964863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
    Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
    Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of HLA antigens in the manifestation and course of Graves' disease.
    Stenszky V; Kozma L; Balazś C; Bear JC; Farid NR
    Mol Biol Med; 1986 Feb; 3(1):53-62. PubMed ID: 3485758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major histocompatibility complex (MHC) factors predisposing to and protecting against Graves' eye disease.
    Frecker M; Mercer G; Skanes VM; Farid NR
    Autoimmunity; 1988; 1(4):307-15. PubMed ID: 2979624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetics of Graves' disease: HLA and disease susceptibility.
    Stenszky V; Kozma L; Balázs C; Rochlitz S; Bear JC; Farid NR
    J Clin Endocrinol Metab; 1985 Oct; 61(4):735-40. PubMed ID: 3861611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HLA B8 and Graves' disease (author's transl)].
    Jaffiol C; Seignalet J; Baldet L; Robin M; Lapinski H; Mirouze J
    Ann Endocrinol (Paris); 1976; 37(4):219-26. PubMed ID: 1037358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA haplotypes and susceptibility to Graves' disease.
    De Rosa G; Testa A; Mariani M; Purpura M; Giacomini D
    Horm Res; 1992; 37(4-5):176-9. PubMed ID: 1490660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graves' disease and HLA: clinical and epidemiologic associations.
    Farid NR; Stone E; Johnson G
    Clin Endocrinol (Oxf); 1980 Dec; 13(6):535-44. PubMed ID: 6894412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA and Graves' disease: an association with HLA-DRw3.
    Allannic H; Fauchet R; Lorcy Y; Heim J; Gueguen M; Leguerrier AM; Genetet B
    J Clin Endocrinol Metab; 1980 Oct; 51(4):863-7. PubMed ID: 6932402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of MHC and Gm in liability to autoimmune thyroid disease.
    Nagataki S
    Mol Biol Med; 1986 Feb; 3(1):73-84. PubMed ID: 3007922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA antigens and thyroid autoantibodies in patients with Graves' disease and their first degree relatives.
    Mather BA; Roberts DF; Scanlon MF; Mukhtar ED; Davies TF; Smith BR; Hall R
    Clin Endocrinol (Oxf); 1980 Feb; 12(2):155-63. PubMed ID: 6893172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism of the fourth component of complement in Graves' disease and type I diabetes mellitus.
    Skanes V; Larsen B; Sampson-Murphy L; Farid NR
    Clin Invest Med; 1985; 8(2):126-32. PubMed ID: 3869086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CTLA4 region as a general autoimmunity factor: an extended pedigree provides evidence for synergy with the HLA locus in the etiology of type 1 diabetes mellitus, Hashimoto's thyroiditis and Graves' disease.
    Einarsdottir E; Söderström I; Löfgren-Burström A; Haraldsson S; Nilsson-Ardnor S; Penha-Goncalves C; Lind L; Holmgren G; Holmberg M; Asplund K; Holmberg D
    Eur J Hum Genet; 2003 Jan; 11(1):81-4. PubMed ID: 12529710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA antigens in a family with both parents and several siblings affected by Graves' disease.
    Fernández Castañer M; Potau MA; Reus JC; Ercilla MG
    Acta Endocrinol (Copenh); 1983 Apr; 102(4):535-8. PubMed ID: 6405574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.